About a year ago, I wrote an article on biotech and said that I was minded to stick by my biotech and healthcare investments – Biotech Growth (BIOG), Worldwide Healthcare (WWH) and Syncona (SYNC). In retrospect, this doesn’t look like a great idea. Over the past 12 months, BIOG and SYNC’s shares are down by […]
2021 was a difficult year for small cap biotech and this shows in RTW Venture’s results. Over the course of the year, the NAV fell by 13% and the share price by 5%. That compares to a 1% return on the NASDAQ Biotech Index and a -27% return on the Russell 2000 Biotech Index (which […]
Swiss investment company BB Biotech (SWX:BION) closed 2021 with its shares trading at CHF77.15, a rise by 8.3% over the year. However, the positive stock performance contrasts with an 11.4% fall in its NAV to CHF59.4/share in 2021, which was adversely affected by the severe bear market for biotech – and particularly its small to […]
Tough year for International Biotechnology but confidence remains – International Biotechnology (IBT) has published its annual results for the year to 31 August 2021. During this time, the company’s NAV per share and share price returned 9.8% and 3.8% respectively whilst the Nasdaq Biotechnology Index returned 22.8%. The board said while this is a disappointing […]
Biotech Growth Trust has struggled this year but this might have created a good entry point for long-term investors September 23, 2021, Investors Chronicle, By Mary McDougall Biotechnology is an area from which some of the world’s most exciting innovations emerge. But as seasoned healthcare investors know, it’s a sector that can deliver heavy losses as well […]
Handbrake off in growth drive Aberdeen Standard European Logistics Income’s (ASLI’s) manager has taken a prudent approach to growing the fund thus far, taking a little-and-often capital raise strategy to improve the quality of the portfolio. However, it now proposes a £75m placing to help fund an identified investment pipeline worth €165m and take advantage […]
Handbrake off in growth drive Aberdeen Standard European Logistics Income’s (ASLI’s) manager has taken a prudent approach to growing the fund thus far, taking a little-and-often capital raise strategy to improve the quality of the portfolio. However, it now proposes a £75m placing to acquire assets from an identified investment pipeline worth €165m and take […]
Handbrake off in growth drive Aberdeen Standard European Logistics Income’s (ASLI’s) manager has taken a prudent approach to growing the fund thus far, taking a little-and-often capital raise strategy to improve the quality of the portfolio. However, it now proposes a £75m placing to help fund an identified investment pipeline worth €165m and take advantage […]
BB Biotech’s (SWX:BION) large position in US covid vaccine producer Moderna drove a strong performance against a volatile US biotech market in the first half of this year. Moderna was the second best performer within BB Biotech’s portfolio during the period, with a rise of 105%, beaten only by Essa Pharmaceuticals, whose stock was up […]
Atlantis Japan Growth (AJG) has announced its annual results for the year ended 30 April 2021., during which it significantly outperformed the TOPIX Total Return Index. During the year, AJG provided an NAV total return of 22.9% and a share price total return of 31.3%, both significantly ahead of those of the TOPIX Total Return […]
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated
